Digging deeper into precision/personalized medicine: cracking the sugar code, the third alphabet of life, and sociomateriality of the cell

Basit Öğe Kaydı
dc.authoridSemra Şardaş / 0000-0001-5456-8636en_US
dc.authorscopusidSemra Şardaş / 7003286974
dc.authorwosidSemra Şardaş / J-2175-2018
dc.contributor.authorÖzdemir, Vural
dc.contributor.authorArga, K. Yalçın
dc.contributor.authorAziz, Ramy K.
dc.contributor.authorBayram, Mustafa
dc.contributor.authorConley, Shannon N.
dc.contributor.authorDandara, Collet
dc.contributor.authorEndrenyi, Laszlo
dc.contributor.authorFisher, Erik
dc.contributor.authorGarvey, Colin K.
dc.contributor.authorHekim, Nezih
dc.contributor.authorKunej, Tanja
dc.contributor.authorŞardaş, Semra
dc.contributor.authorVon Schomberg, Rene
dc.contributor.authorYassin, Aymen S.
dc.contributor.authorYılmaz, Gürcim
dc.contributor.authorWang, Wei
dc.date.accessioned2020-08-30T20:06:17Z
dc.date.available2020-08-30T20:06:17Z
dc.date.issued2020
dc.departmentİstinye Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümüen_US
dc.description.abstractPrecision/personalized medicine is a hot topic in health care. Often presented with the motto "the right drug, for the right patient, at the right dose, and the right time," precision medicine is a theory for rational therapeutics as well as practice to individualize health interventions (e.g., drugs, food, vaccines, medical devices, and exercise programs) using biomarkers. Yet, an alien visitor to planet Earth reading the contemporary textbooks on diagnostics might think precision medicine requires only two biomolecules omnipresent in the literature: nucleic acids (e.g., DNA) and proteins, known as the first and second alphabet of biology, respectively. However, the precision/personalized medicine community has tended to underappreciate the third alphabet of life, the "sugar code" (i.e., the information stored in glycans, glycoproteins, and glycolipids). This article brings together experts in precision/personalized medicine science, pharmacoglycomics, emerging technology governance, cultural studies, contemporary art, and responsible innovation to critically comment on the sociomateriality of the three alphabets of life together. First, the current transformation of targeted therapies with personalized glycomedicine and glycan biomarkers is examined. Next, we discuss the reasons as to why unraveling of the sugar code might have lagged behind the DNA and protein codes. While social scientists have historically noted the importance of constructivism (e.g., how people interpret technology and build their values, hopes, and expectations into emerging technologies), life scientists relied on the material properties of technologies in explaining why some innovations emerge rapidly and are more popular than others. The concept of sociomateriality integrates these two explanations by highlighting the inherent entanglement of the social and the material contributions to knowledge and what is presented to us as reality from everyday laboratory life. Hence, we present a hypothesis based on a sociomaterial conceptual lens: because materiality and synthesis of glycans are not directly driven by a template, and thus more complex and open ended than sequencing of a finite length genome, social construction of expectations from unraveling of the sugar code versus the DNA code might have evolved differently, as being future-uncertain versus future-proof, respectively, thus potentially explaining the "sugar lag" in precision/personalized medicine diagnostics over the past decades. We conclude by introducing systems scientists, physicians, and biotechnology industry to the concept, practice, and value of responsible innovation, while glycomedicine and other emerging biomarker technologies (e.g., metagenomics and pharmacomicrobiomics) transition to applications in health care, ecology, pharmaceutical/diagnostic industries, agriculture, food, and bioengineering, among others.en_US
dc.identifier.citationÖzdemir, V., Arga, K. Y., Aziz, R. K., Bayram, M., Conley, S. N., Dandara, C., ... & Kunej, T. (2020). Digging deeper into precision/personalized medicine: Cracking the sugar code, the third alphabet of life, and sociomateriality of the cell. OMICS: A Journal of Integrative Biology, 24(2), 62-80.en_US
dc.identifier.doi10.1089/omi.2019.0220en_US
dc.identifier.endpage80en_US
dc.identifier.issn1536-2310en_US
dc.identifier.issn1557-8100en_US
dc.identifier.issue2en_US
dc.identifier.pmid32027574en_US
dc.identifier.scopus2-s2.0-85080845863en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage62en_US
dc.identifier.urihttps://doi.org/10.1089/omi.2019.0220
dc.identifier.urihttps://hdl.handle.net/20.500.12713/455
dc.identifier.volume24en_US
dc.identifier.wosWOS:000514263000003en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorŞardaş, Semraen_US
dc.language.isoenen_US
dc.publisherMary Ann Liebert, Incen_US
dc.relation.ispartofOmics-A Journal of Integrative Biologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCellular Communicationen_US
dc.subjectContemporary Arten_US
dc.subjectEmerging Technology Governanceen_US
dc.subjectGlycansen_US
dc.subjectHistory Of Scienceen_US
dc.subjectPersonalized Medicineen_US
dc.subjectPharmacoglycomicsen_US
dc.subjectResponsible Innovationen_US
dc.subjectSociomaterialityen_US
dc.subjectSugar Codeen_US
dc.titleDigging deeper into precision/personalized medicine: cracking the sugar code, the third alphabet of life, and sociomateriality of the cellen_US
dc.typeReview Articleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
95.pdf
Boyut:
475.55 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Eczacılık Meslek Bilimleri Bölümü Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu